By understanding how the body responds to a COVID-19 infection – when the virus breaches our body, starts replicating and spreads through the bloodstream – immunologist Dr Larisa Labzin hopes to identify where the disease can be stopped in its tracks.
Scientists around the world are continuing to test countless vaccines and drugs in the hope of finding effective ways to prevent and treat COVID-19. Among the trials happening in Australia is OM85.
The University of Queensland’s COVID-19 vaccine has passed another important milestone, showing the ability to raise high levels of antibodies that can neutralise the virus in early pre-clinical testing.
UQ PhD Graduate, Dr Rahmat Shazi, is part of a group of Malaysian professionals volunteering their time and expertise to develop innovative medical and delivery devices helping the country fight the COVID-19 crisis.
Nearly two million “rapid” antibody tests imported into Australia have been declared useless for determining whether someone has been exposed to the COVID-19 coronavirus.
UQ has secured over $5.7 million in government funding under the Medical Research Future Fund's (MRFF) Genomics Health Futures Mission for three projects that will advance the diagnosis of breast cancer, paediatric sepsis, and study the ethics of genomics and disabilities.
Queensland researchers are leading a worldwide clinical study using AI to examine COVID-19 patient data from 300 intensive care units (ICU) to provide insight for health professionals to determine the best treatments for the disease.
Queensland hospitals have started testing two potential treatments on patients with COVID-19 as part of an international clinical trial involving The University of Queensland.
